Valproate in acute mania: Is our practice evidence based?

International Journal of Health Care Quality Assurance

Volumn 25, Issue 1, 2012, Pages 41-52

  Vasudev, Kamini ^a   Mead, Anna ^b   Macritchie, Karine ^c   Young, Allan H ^c  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b LD Psychology Services South Tyneside   (United Kingdom)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Auditing guidelines; Bipolar disorder; Clinical audit; Drug administration; Evidence based guidelines; Mania; United Kingdom; Valproate

Indexed keywords

NEUROLEPTIC AGENT; TRANQUILIZER; VALPROIC ACID;

ACUTE DISEASE; ADULT; BIPOLAR DISORDER; CHEMISTRY; CLINICAL PRACTICE; DRUG COMBINATION; EVIDENCE BASED PRACTICE; FEMALE; HOSPITAL PATIENT; HUMAN; MALE; MEDICAL AUDIT; PSYCHIATRIC DEPARTMENT; REVIEW; STANDARD; STATISTICS; UNITED KINGDOM;

ACUTE DISEASE; ADULT; ANTIMANIC AGENTS; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; CHEMISTRY, PHARMACEUTICAL; CLINICAL AUDIT; DRUG THERAPY, COMBINATION; EVIDENCE-BASED PRACTICE; FEMALE; GREAT BRITAIN; HUMANS; INPATIENTS; MALE; PHYSICIAN'S PRACTICE PATTERNS; PSYCHIATRIC DEPARTMENT, HOSPITAL; VALPROIC ACID;

EID: 84855564157     PISSN: 09526862     EISSN: None     Source Type: Journal    
DOI: 10.1108/09526861211192395     Document Type: Review

References (28)

1. Allen, M.H., Hirschfeld, R.M., Wozniak, P.J., Baker, J.D. and Bowden, C.L. (2006), "Linear relationship of valproate serum concentration to response and optimal serum levels for acute mania" in American Journal of Psychiatry, Vol. 163, No. 2, pp. 272-5.
2. American Psychiatric Association (2000), Diagnostic and Statistical Manual of Mental Disorders, 4th ed., text revision, American Psychiatric Association, Washington, DC.
3. American Psychiatric Association (2002), "Practice guideline for the treatment of patients with bipolar disorder" in American Journal of Psychiatry, Vol. 159, April, supplement, pp. 1-50.
4. Australian and New Zealand Journal of Psychiatry (2004), "Australian and New Zealand Clinical Practice guidelines for the treatment of Bipolar disorder" in Vol. 38, No. 5, pp. 280-305.
5. British National Formulary (BNF) (2009), available at: www.bnf.org/bnf/bnf/current.
6. Bowden, C.L., Brugger, A.M., Swann, A.C., Calabrese, J.R., Janicak, P.G., Petty, F., Dilsaver, S.C., Davis, J.M., Rush, A.J., Small, J.G., Mania Study Group, The Depakote (1994), "Efficacy of divalproex versus lithium and placebo in the treatment of mania" in Journal of American Medical Association, Vol. 271, pp. 918-24.
7. Bowden, C.L., Janicak, P.G., Orsulak, P., Swann, A.C., Davis, J.M., Calabrese, J.R., Goodnick, P., Small, J.G., Rush, A.J., Kimmel, S.E., Risch, S.C. and Morris, D.D. (1996), "Relation of serum valproate concentration to response in Mania" in American Journal of Psychiatry, Vol. 153, pp. 765-70.
8. Bowden, C.L., Swann, A.C., Calabrese, J.R., Rubenfaer, L.M., Wozniak, P.J., Collins, M.A., Abi-Saab, W., Saltarelli, M., Depakote, E.R., Study Group, Mania (2006), "A randomized, placebo-controlled, multicenter study of divalproex sodium extended release in the treatment of acute mania" in Journal of Clinical Psychiatry, Vol. 67, No. 10, pp. 1501-10.
9. Bowden, C.L., Calabrese, J.R., McElroy, S.L., Gyulai, L., Wassef, A., Petty, F., Pope, H.G. Jr, Chou, J.C., Keck, P.E. Jr, Rhodes, L.J., Swann, A.C., Hirschfeld, R.M. and Wozniak, P.J. (2000), "A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder" in Archives of General Psychiatry, Vol. 57, No. 5, pp. 481-9.
10. Canadian Network for Mood and Anxiety Treatments (CANMAT) (2005), "Guidelines for the management of patients with bipolar disorder: consensus and controversies" in Bipolar disorders, Vol. 7, Supplement 3, pp. 5-69.
11. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT (2009), "Guidelines for the management of patients with bipolar disorder: update" in Bipolar Disorders, Vol. 11, No. 3, pp. 225-55.
12. Fisher, C. and Broderick, W. (2003), "Sodium valproate or valproate semi-sodium: is there a difference in the treatment of bipolar disorder?" in Psychiatric Bulletin, Vol. 27, pp. 446-8.
13. Freeman, T.W., Clothier, J.L., Pazzaglia, P., Lesem, M.D. and Swann, A.C. (1992), "A double-blind comparison of valproate and lithium in the treatment of acute mania" in American Journal of Psychiatry, Vol. 149, No. 1, pp. 108-11.
14. Goodwin, G.M. (2003), "Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology" in Journal of Psychopharmacology, Vol. 17, No. 2, pp. 149-73.
15. Goodwin, G.M. (2009), "Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology" in Journal of Psychopharmacology, Vol. 23, No. 4, pp. 346-88.
16. Hirschfeld, R.M.A., Allen, M.H., McEvoy, J.P., Keck, P.E. Jr and Russell, J.M. (1999), "Safety and tolerability of oral loading divalproex sodium in acutely manic bipolar patients" in Journal of Clinical Psychiatry, Vol. 60, No. 12, pp. 815-8.
17. Hirschfeld, R.M.A., Baker, J.D., Wozniak, P., Tracy, K. and Sommerville, K. (2003), "The safety and early efficacy of oral-loaded divalproex versus standard-titration divalproex, lithium, olanzapine, and placebo in the treatment of acute mania associated with bipolar disorder" in Journal of Clinical Psychiatry, Vol. 64, pp. 841-6.
18. Keck, P.E. Jr, McElroy, S.L., Tugrul, K.C. and Bennett, J.A. (1993), "Valproate oral loading in the treatment of acute mania" in Journal of Clinical Psychiatry, Vol. 54, No. 8, pp. 305-8.
19. McElroy, S.L., Keck, P.E., Stanton, S.P., Tugrul, K.C., Bennett, J.A. and Strakowski, S.M. (1996), "A randomized comparison of divalproex oral loading versus haloperidol in the initial treatment of acute psychotic mania" in Journal of Clinical Psychiatry, Vol. 57, No. 4, pp. 142-6.
20. Muller-Oerlinghausen, B., Retzow, A., Henn, F.A., Giedke, H. and Walden, J. (2000), "Valproate as an adjunct to neuroleptic medication for the treatment of acute episodes of mania: a prospective, randomised, double-blind, placebo-controlled, multicentre study, European Valproate Mania Study Group" in Journal of Clinical Psychopharmacology, Vol. 20, No. 2, pp. 195-203.
21. National Institute for Health and Clinical Excellence (2006), Clinical guidelines on Bipolar Disorder Bipolar Disorder: The Management of Bipolar Disorder in Adults, Children and Adolescents, in Primary and Secondary Care, National Collaborating Centre for Mental Health, London.
22. Pope, H.G., McElroy, S.L., Keck, P.E. Jr and Hudson, J.I. (1991), "Valproate in the treatment of acute mania" in Archives of General Psychiatry, Vol. 48, No. 1, pp. 62-8.
23. Soares-Weiser, K., Bravo, V.Y., Beynon, S., Dunn, G., Barbieri, M. and Duffy, S. (2007), "A systematic review and economic model of the clinical effectiveness and cost-effectiveness of interventions for preventing relapse in people with bipolar disorder", Health Technology Assessment, Vol. 11, No. 39, pp. iii-iv, ix-206.
24. Tohen, M., Baker, R.W., Altshuler, L.L., Zarate, C.A., Suppes, T., Ketter, T.A., Milton, D.R., Risser, R., Gilmore, J.A., Breier, A. and Tollefson, G.A. (2002), "Olanzapine Versus Divalproex in the treatment of acute mania" in American Journal of Psychiatry, Vol. 159, No. 6, pp. 1011-7.
25. Vasudev, K., Goswami, U. and Kohli, K. (2000), "Carbamazepine and valproate monotherapy: feasibility, relative safety and efficacy, and therapeutic drug monitoring in manic disorder" in Psychopharmacology, Vol. 150, No. 1, pp. 15-23.
26. Vieta, E. and Sanchez-Moreno, J. (2008), "Acute and long-term treatment of mania" in Dialogues in Clinical Neurosciences, Vol. 10, No. 2, pp. 165-79.
27. Wheeler, A., Robinson, G. and Fraser, A. (2008), "Mood stabilizer loading versus titration in acute mania: audit of clinical practice" in Australian and New Zealand Journal of Psychiatry, Vol. 42, No. 11, pp. 955-62.
28. Zajecka, J.M., Weisler, R., Sachs, G., Swann, A.C., Wozniak, P. and Sommerville, K.W. (2002), "A comparison of the efficacy, safety and tolerability of divalproex sodium and olanzapine in the treatment of bipolar disorder" in Journal of Clinical Psychiatry, Vol. 63, No. 12, pp. 1148-55.